The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Trek, thankyou, Sir. Much appreciated. That deck was quite helpful, I quite liked the peer group analysis page. Based on the interim results from the Blautix trial I think we may be in for quite a positive final readout
Hi all,
just looking in on DDDD, could anyone provide a summary of the near term newsflow expected here? I see lots of talk for it to get to 60/70/beyond, what is expected to take this there?
thanks
Not really a first, money is given in a non dilutive way all the time. Ive pasted the results of a simple google search on the topic below, it is US specific but similar initiatives exist in other countries aswell. Besides none of this is an issue atm as there is sufficient funds to the end of the year
Types of Non-Dilutive Financing
There’s a wide variety of capital sources considered non-dilutive. Here are just a few sources that can inject capital into the business without giving up ownership.
Loans generally require a credit check, collateral, and guarantors. And they must be paid back with interest.
Grants, on the other hand, do not need to be repaid. There are several different types of grants for small businesses and start-ups. Usually, they require the submission of an application and, most of time, are tied to a specific project or business milestone. And the business is generally required to provide status reports on the project and/or the business milestones.
SBIR and STTR Programs offer funding from small seed grants for risky research to large, multi-year contracts that support multi-faceted programs. These programs focus primarily on projects that support the US Government through the Department of Defense (DoD), National Institute of Health (NIH), Department of Energy (DoE), and many others. SBIRs/STTRs are a great way for businesses to work out the kinks of their technology and products before reaching full commercialization.
Licensing is a good way to get upfront payments from industry partners as well as regular monthly or quarterly payments to fund the business and additional development.
Royalty Financing allows the business to receive cash in exchange for a percentage of the company’s future revenues over a certain period and up to a certain amount.
Tax Credits offset past, current, or future tax a business generates. They can be refundable or non-refundable, meaning that the business receives them even if there was no tax generated (refundable) or only if tax was owed (non-refundable).
Tax Credits as Non-Dilutive Capital
Tax Credits are probably the simplest way to inject non-dilutive capital into the business. These dollars are already available to taxpayers and are guaranteed by Federal or State law. For eligible companies, Tax Credits can be combined with other capital sources to make the funding go further. Also, because Tax Credits dollars are nondescript, they can be used to fund costs that were not used to compute the credits such as marketing, HR, employee benefits, employee engagement, technology infrastructure, etc.
State and Local Incentives are meant to fuel business activity and growth in a state, county, city, or municipality. They generally range from tax incentives for hiring employees in the area (very common) to providing capital for a construction project. Programs vary from state to state but are available to most
couple of points from the covid update which address the placing fears being raised:
"The Company has determined cash preservation is of paramount importance in this challenging environment. As such, immediate cost reduction measures have been implemented. Based on current information available it is expected that the Company has sufficient funding runway until the end of the year. This is well beyond Q3 according to previous guidance, and should reassure shareholders in the wake of recent pandemic related events."
And;
"the Company had recently engaged a boutique corporate advisory firm outside the UK with a successful track record in funding early stage consumer restaurant tech. This was done with a view to funding growth without the need for an equity placing."
so would be careful on any prima facie analysis. Could very well be 'big' and 'very big' buys
current price of a GDR kit is £8 on the low side, in countries like India, kit prices are more than double that. GDR is one of the cheapest tests even on the Indian market
We saw how in March when the first wave of Coronovirus hit Europe the main markets tumbled but diagnostics firms producing tests for Covid, later becoming amongst those known as 'Covid Stocks', rallied by 1,000s of %.
These stocks retraced from their highs over the past few weeks as Corona was bought under control, simultaneously, the main markets rallied. With talks of a second wave, increasing numbers of infections and the worst performance by the major markets yesterday since those March falls, we are likely to see those same Covid Stocks witness rallies as it becomes apparent the requirement for testing has not diminished but is rather being further ramped up.
worst day for the markets since the first lockdown in March today, if anyone wants to see what will happen to covid sticks they need only look at what happened to covid stocks then
thanks, cminhinnet
yes, thats what google says - £2.80, that's massive from current levels
So what was the last price traded before suspension? Can't get access to any Time and Sales because it's still suspended
Is it correct that this was at 280P in April before suspension? Is that where this is going back to?
dreammachine -aint doom mongering just encouraging people to sell and rainbow chase
Islandgirl - hadnt heard of 'it aint half hot mum' before so googled it, watched a quick clip on youtube - looks hilarious!
the phrase "buy when others are fearful" springs to mind. Fundamentals are solid here, a test which is of the highest accuracy on the market, one of the easiest if not the easiest to administer, easiest to transport,, regulatory approved and demand is soaring in target markets with sales activity taking place right now and additional approvals being processed.
Yes, for GDR Arkray is the main distributor in India and Sysmex also has operations in the region
the sales indiction is given by need, which atm is significant. you wont be able to price GDR off the first sales contract, that's a silly approach as that won't be the sum total of Sales.
if you want to see where Sales will potentially be, look at demand
what the heck has indians using computers and being literate got to do with government testing for covid.
this is what i mean when i say you dont know what you're on about and are out here with your baseless ramping kicking a share when it's down for your own selfish gain
Indian Gov has set a R4,500 limit on testing, several states are operating at half that, R2,250, the lowest price is R2,000.
THose numbers equate to £47, £23, and £20. GDR at £8 would be the cheapest and arguably best test on the Indian market